Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in "Real Life"

Etelcalcetide is a new calcimimetic indicated for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients. Etelcalcetide efficacy in SHPT has been ascertained only in randomized controlled trials. This multicenter study was carried out in "real world" setting that is dif...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical medicine 2019-07, Vol.8 (7), p.1066
Hauptverfasser:	Russo, Domenico, Tripepi, Rocco, Malberti, Fabio, Di Iorio, Biagio, Scognamiglio, Bernadette, Di Lullo, Luca, Paduano, Immacolata Gaia, Tripepi, Giovanni Luigi, Panuccio, Vincenzo Antonio
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!